OpenAlex
PricingAboutJobs
Log inGet started
Work

Risks of Serious Infection or Lymphoma With Anti–Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review

HTML PDF

Year: 2014
Type: review
Source: Clinical Gastroenterology and Hepatology
DOI: 10.1016/j.cgh.2014.01.021
Authors: Parambir S. Dulai, Kimberly D. Thompson, Heather B. Blunt, Marla C. Dubinsky, Corey A. Siegel
Institutions: Dartmouth–Hitchcock Medical Center, Dartmouth College, Dartmouth Health, Cedars-Sinai Medical Center
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: anti-tumor necrosis factor therapy, pediatric inflammatory bowel disease, Crohn's disease, ulcerative colitis, infliximab, adalimumab, serious infections, lymphoma, lymphoid malignancies, non-relapse mortality, sepsis, corticosteroid therapy, standardized incidence ratio, drug safety, pediatric patients
SDG: Good health and well-being

Open Access status: bronze

Funders: Crohn's and Colitis Foundation, Agency for Healthcare Research and Quality
Awards: EVALUATING A PREDICTION TOOL AND DECISION AID FOR PATIENTS WITH CROHN'S DISEASE, Evaluating a Prediction Tool and Decision Aid for Patients with Crohn's Disease
OpenAlex ID: W1996063338
FWCI: 2.852
Cites: 95
Cited by: 165
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms